Nuevolution A/S
USPTO PatentsView assignee record - 25 granted patents across 12 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Nuevolution ranks #12,145 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 12 technology areas.
- #12,145
- of 49,997 US assignees by volume
- Top 26%
- by Innovation Score (44.4/100)
- 51.5
- avg claims per patent
- +78%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12145 · Foreign Corporation #12,145 · 25 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 25 grants
- UPPER-Q #12,145/49,997
- PHOTO-FINISH National Coupling
- CPC-FOCUS C12N · 12 areas
- INNOV-PAR 44.4/100
- CLAIMS-DENSE 51.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +78% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: National Coupling Company, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nuevolution’s 44.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nuevolution
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Crispr Therapeutics · near
Crispr Therapeutics · near
44 score
- NantBio · near
NantBio · near
44 score
- National Chain · near
National Chain · near
44 score
- Nuevolution A/S · this assignee
Nuevolution A/S · this assignee
44 score
- Sunnybrook Health… · near
Sunnybrook Health… · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nuevolution's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nuevolution?
Each dot is one of Nuevolution’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nuevolution’s own 51.5 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Nuevolution's grants concentrate
Nuevolution A/S is a focused PatentsView assignee: 12 CPC subclasses with 68% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2016. By volume, Nuevolution sits between Netzsch Pumpen & Systeme GmbH and NoNO Inc..
Nuevolution's three-year grant acceleration
Nuevolution A/S shows 8 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Nuevolution's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Netzsch Pumpen &…
Netzsch Pumpen & Systeme GmbH
25 patents
- NKT HV Cables AB
NKT HV Cables AB
25 patents
- Norsk Hydro ASA
Norsk Hydro ASA
25 patents
- NP Medical
NP Medical Inc.
25 patents
- National Coupling
National Coupling Company, Inc.
25 patents
- Naver Business Pl…
Naver Business Platform Corporation
25 patents
- Nimbus Lakshmi
Nimbus Lakshmi, Inc.
25 patents
- Nono
NoNO Inc.
25 patents
- Nuevolution A/S ◀
Nuevolution A/S
25 patents
What this shows Nuevolution holds 25 patents at rank #12,136, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nuevolution
By rank, the assignees closest to #12,136 in granted patent volume.
- Netzsch Pumpen & Systeme GmbH #12,132 · 25 patents
- NKT HV Cables AB #12,133 · 25 patents
- Norsk Hydro ASA #12,134 · 25 patents
- NP Medical Inc. #12,135 · 25 patents
- National Coupling Company, Inc. #12,137 · 25 patents
- Naver Business Platform Corporation #12,138 · 25 patents
- Nimbus Lakshmi, Inc. #12,139 · 25 patents
- NoNO Inc. #12,140 · 25 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Nuevolution's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Nuevolution, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Nuevolution ranks #632 of 4,144 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Nuevolution's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 16.0% |
| 2016 | 1 | 4.0% |
| 2017 | 1 | 4.0% |
| 2018 | 2 | 8.0% |
| 2019 | 1 | 4.0% |
| 2020 | 6 | 24.0% |
| 2021 | 2 | 8.0% |
| 2022 | 3 | 12.0% |
| 2023 | 4 | 16.0% |
| 2024 | 1 | 4.0% |
Which technologies does Nuevolution A/S patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Nuevolution A/S's patent record in context - here's where to go next.
- Nuevolution A/S's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 68% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #12,145 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Nuevolution A/S against Netzsch Pumpen & Systeme GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.